Obstructive sleep apnoea in acromegaly: the role of craniofacial changes

Obstructive sleep apnoea (OSA) is due to craniofacial changes and acromegaly. The question addressed by this study was whether growth hormone (GH) induced craniofacial changes might explain persisting OSA despite endocrine inactivity in acromegaly. Nineteen patients treated for acromegaly were examined cephalometrically for craniofacial changes and polysomnographically for OSA. Twelve patients proved to have OSA with an apnoea/hypopnoea index >15; seven patients showed no evidence of OSA at all. With respect to the endocrinological parameters, there were no differences between the two groups that would explain the presence or absence of OSA. Neither group differed with respect to sex, age, or body mass index. Craniofacial changes were predominantly found in the mandible. The group with OSA proved to have increased vertical, dolichofacial growth compared to those without OSA. Consecutively, in the OSA group the posterior airway space was narrowed, and the hyoid was displaced more caudally. Thus, it seems that craniofacial structures of patients with acromegaly and persisting obstructive sleep apnoea are different from those without obstructive sleep apnoea. Surgical corrections of pertaining acromegaly-induced craniofacial changes should be performed with an awareness of the individual craniofacial condition so as not to enhance obstructive sleep apnoea.

This article has been cited by other articles:

				C Berg, T E Wessendorf, F Mortsch, M Forsting, H Teschler, T Weischer, K Mann, B Saller, and B L Herrmann Influence of disease control with pegvisomant on sleep apnoea and tongue volume in patients with active acromegaly Eur. J. Endocrinol., December 1, 2009; 161(6): 829 - 835. [Abstract] [Full Text] [PDF]

				P. Attal, V. Claes, S. Bobin, P. Chanson, P. Kamenicky, P. Zizzari, and Y. Lecarpentier Growth hormone excess and sternohyoid muscle mechanics in rats Eur. Respir. J., October 1, 2009; 34(4): 967 - 974. [Abstract] [Full Text] [PDF]

				R. D. Vorona Sleep, Sleep Disorders, and the Endocrine System ACCP Sleep Med Brd Rev, January 1, 2009; 4(0): 163 - 184. [Full Text] [PDF]

				M. V. Davi', L. D. Carbonare, A. Giustina, M. Ferrari, A. Frigo, V. Lo Cascio, and G. Francia Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease Eur. J. Endocrinol., November 1, 2008; 159(5): 533 - 540. [Abstract] [Full Text] [PDF]

				F. R B van Haute, G. F Taboada, L. L Correa, G. A B Lima, R. Fontes, A. P. Riello, M. Dominici, and M. R Gadelha Prevalence of sleep apnea and metabolic abnormalities in patients with acromegaly and analysis of cephalometric parameters by magnetic resonance imaging. Eur. J. Endocrinol., April 1, 2008; 158(4): 459 - 465. [Abstract] [Full Text] [PDF]

				L. Sze, C. Schmid, K. E Bloch, R. Bernays, and M. Brandle Effect of transsphenoidal surgery on sleep apnoea in acromegaly Eur. J. Endocrinol., March 1, 2007; 156(3): 321 - 329. [Abstract] [Full Text] [PDF]

				C. M. Ryan and T. D. Bradley Pathogenesis of obstructive sleep apnea J Appl Physiol, December 1, 2005; 99(6): 2440 - 2450. [Abstract] [Full Text] [PDF]

				A. Colao, D. Ferone, P. Marzullo, and G. Lombardi Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management Endocr. Rev., February 1, 2004; 25(1): 102 - 152. [Abstract] [Full Text] [PDF]

				H. Derendorf, P.T. Daley-Yates, L.N. Pierre, and J. Efthimiou Systemic bioavailability of inhaled steroids: the importance of appropriate and comparable methodology Eur. Respir. J., January 1, 2001; 17(1): 157 - 158. [Full Text] [PDF]